Literature DB >> 14517663

Monitoring of skeletal muscle oxygenation using near-infrared spectroscopy during abdominal aortic surgery.

Masayasu Nakayama1, Soushi Iwasaki, Hiromichi Ichinose, Shuji Yamamoto, Noriaki Kanaya, Akiyoshi Namiki.   

Abstract

PURPOSE: To examine the utility of near-infrared spectroscopy (NIRS) in assessing lower-leg perfusion, NIRS was performed on the calf muscles of patients who underwent abdominal aortic surgery.
METHODS: Thirty patients undergoing elective infrarenal abdominal aortic surgery for abdominal aortic aneurysm (AAA group; n = 16) and aorto-occlusive disease (AOD group; n = 14) were studied. Before induction of anesthesia, NIRS probes were placed over both calf muscles, and muscle oxygen saturation (S(tO2)) was continuously monitored throughout the surgery.
RESULTS: The preoperative S(tO2) value was significantly lower in the AOD group (57.0 +/- 11.2%) than in the AAA group (68.7 +/- 7.0%). In both groups, S(tO2) significantly decreased after aortic cross-clamping; the maximal ischemic value of S(tO2) in the AAA group (17.8 +/- 7.2%) was significantly lower than that in the AOD group (46.7 +/- 17.1%). The time taken to reach maximal ischemia was significantly longer in the AAA group (30 +/- 12 min) than in the AOD group (19 +/- 12 min). After release of the aortic clamp, the decreased S(tO2) returned to the preoperative level in the AAA group, whereas it increased above the preoperative value in the AOD group.
CONCLUSION: NIRS performed on the calf muscles is a useful method for assessing the changes in lower-leg perfusion during and after abdominal aortic surgery.

Entities:  

Year:  2002        PMID: 14517663     DOI: 10.1007/s005400200007

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  1 in total

1.  The usefulness of near-infrared spectroscopy in the anesthetic management of endovascular aortic aneurysm repair.

Authors:  Masahiro M Wakimoto; Mamoru Kadosaki; Hirofumi Nagata; Kenji S Suzuki
Journal:  J Anesth       Date:  2012-06-26       Impact factor: 2.078

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.